Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Journal of Lipid Research|January 18, 2005
Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesisPeter Tobias, Linda K CurtissSeminars in Immunopathology|December 7, 2007
TLR2 in murine atherosclerosisPeter S Tobias, Linda K CurtissJournal of Lipid Research|November 5, 2008
Emerging role of Toll-like receptors in atherosclerosisLinda K Curtiss, Peter S TobiasJournal of Lipid Research|November 6, 2007
Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient miceRamona J Petrovan, Yuan Yuan, Linda K CurtissArteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2002
Inflammation in atherosclerosis: lesion formation in LDL receptor-deficient mice with perforin and Lyst(beige) mutationsNatalie K Schiller, William A Boisvert, Linda K CurtissImmunologic Research|August 8, 2006
Toll-like receptors and atherosclerosis: key contributors in disease and health?Adam E Mullick, Peter S Tobias, Linda K CurtissThe Journal of Clinical Investigation|October 8, 2005
Modulation of atherosclerosis in mice by Toll-like receptor 2Adam E Mullick, Peter S Tobias, Linda K CurtissJournal of Lipid Research|August 3, 2011
Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sitesJeffrey L Pitman, David J Bonnet, Linda K Curtiss, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 2005
What is so special about apolipoprotein AI in reverse cholesterol transport?Linda K Curtiss, David T Valenta, Neil J Hime, et al.Journal of Lipid Research|October 12, 2007
Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiencyDavid T Valenta, Joshua J Bulgrien, David J Bonnet, et al.Pageof 5